Mouse anti Human Matrix Metalloproteinase 9 (MMP9)Catalog number: X2057M
The matrix metalloproteinases (MMP) are a family of peptidase enzymes responsible for the degradation of extracellular matrix components, including collagen, gelatin, fibronectin, laminin and proteoglycan. Transcription of MMP genes is differentially activated by phorbol ester, lipopolysaccharide (LPS) or staphylococcal enterotoxin B (SEB). MMP catalysis requires both calcium and zinc. MMP-9 (also designated 92-kDa type IV collagenase or gelatinase B) has been shown to degrade bone collagens in concert with MMP-1 (also designated interstitial collagenase, fibroblast collagenase or collagenase-1), and cysteine proteases and may play a role in bone osteoclastic resorption. MMP-1 is down-regulated by p53, and abnormality of p53 expression may contribute to joint degradation in rheumatoid arthritis by regulating MMP-1 expression.
Synonyms: CLG4B, GELB, 92 kDa gelatinase, matrix metallopeptidase 9
Hybridoma produced by the fusion of splenocytes from BALB/c mice immunized with a synthetic peptide derived from the N-terminus of the human MMP9 protein and mouse myeloma Ag8563 cells. Sequence common in rabbit, dog and pig
Provided as solution in phosphate buffered saline with 0.08% sodium azide
Product Form: Unconjugated
Purification Method: Protein A/G Chromatography
Concentration: See vial for concentration
Antibody can be used for Western blotting (1-2 µg/ml) and immunohistochemistry (1-5 µg/ml). Antibody is specific for the activated form of MMP9 only. These working concentrations are merely an indication. Optimal working concentrations should, however, be evaluated by serial dilutions by the customer.
Functional Analysis: N.A.
Positive Control: Esophageal adenocarcinoma. Only present in tumor tissues.
Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles
Product Stability: See expiration date on vial
Shipping Conditions: Ship at ambient temperature, freeze upon arrival
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Exalpha Biologicals accepts no liability for any inaccuracies or omissions in this information.
1. Wang, L. et al. (2006). Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J. Neurosci. 26(22);5996-6003 2. Solmiari, S.B., et al. (2006). Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int. J. Cancer. 119(6);1403-1411 3. Chen, X., et al. (2005). Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells. Int. J. Cancer. 116(1);52-61
Database Name: UniProt
Accession Number: P14780 (Human)
Species Accession: Human
Safety Datasheet(s) for this product:
|"Left: Immunohistochemical staining of paraffin embedded esophageal tumors using Act-MMP9 antibody (Cat. No. X2057M). Right: Western blot using MMP9 antibody on recombinant human proenzyme MMP9 (left lane) and activated enzyme (right lane)."|
"Left: Immunohistochemical staining of paraffin embedded esophageal tumors using Act-MMP9 antibody (Cat. No. X2057M). Right: Western blot using MMP9 antibody on recombinant human proenzyme MMP9 (left lane) and activated enzyme (right lane)."